United Therapeutics | UTHR - Trade Creditors

Stock Price
568.58
Daily Change
-7.21 -1.25%
Monthly
-2.06%
Yearly
86.21%
Q2 Forecast
557.15

United Therapeutics reported $498.3M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Amarin USD 48.15M 2.8M Mar/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Bayer EUR 6.59B 496M Mar/2026
BioCryst Pharmaceuticals USD 10.96M 4.87M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
Insmed USD 73.38M 6.53M Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
Moderna USD 161M 156M Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 4.51B 734M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
United Therapeutics USD 498.3M 491.2M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026